Automated Microfluidic System with Active Mixing Enables Rapid Analysis of Biomarkers in 5 μL of Whole Blood.

Anal Chem

Department of Physiology and Biomedical Engineering, Mayo Clinic, Rochester, Minnesota 55905, United States.

Published: July 2022

We developed a microfluidic device for the rapid analysis of biomarkers in small volumes of whole blood. This device includes an onboard plasma separation module connected to a downstream bioanalysis module in which plasma mixes with reagents and the results of a colorimetric assay are recorded. Actuation of onboard microvalves within a bioanalysis module creates active mixing conditions that allowed us to achieve solution homogeneity within 5 min. To demonstrate utility, we carried out glucose detection in our device. With 5 μL of whole blood as an input, our microfluidic device enabled a time-to-answer of 10 min with a limit of detection of 0.21 ± 0.04 mM for glucose. This device has immediate applications for rapid and sensitive monitoring of hypoglycemia at the point of care (POC). Furthermore, our automated microfluidic device represents a platform technology that may be used to detect other biomarkers in whole blood.

Download full-text PDF

Source
http://dx.doi.org/10.1021/acs.analchem.2c01139DOI Listing

Publication Analysis

Top Keywords

microfluidic device
12
automated microfluidic
8
active mixing
8
rapid analysis
8
analysis biomarkers
8
μl blood
8
bioanalysis module
8
device
6
microfluidic system
4
system active
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!